Viewing Study NCT01784068

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:35 PM
Ignite Modification Date: 2026-01-03 @ 11:22 AM
Study NCT ID: NCT01784068
Status: COMPLETED
Last Update Posted: 2025-09-10
First Post: 2013-01-30
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myelogenous Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AMN107 View
None Ph+ CML-CP View
None chronic phase View
None nilotinib treatment View
None 2 years treatment View
None MR 4.5 View
None Loss of MR 4 View
None Loss of MMR View
None CML View